References
- Antman K H, Ryan L, Elias A, et al. Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol 1989; 7: 126
- Edmonson J H, Ryan L M, Blum R H, et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 1993; 11: 1269–1275
- Borden E C, Amato D A, Rosenbaum C, et al. Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol 1987; 5: 840–850
- Holmes F A, Walters R S, Theriault R L, et al. Phase II trial of taxol. an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 1991; 83: 1778–1781
- Seidman A D, Hochhauser D, Yao T J, et al. 96 hour paclitaxel after prior short taxane infusion: phase II pharmacokinetic (PK) and pharmacodynamic (PD) study in metastatic breast cancer. Proc Am Soc Clin Oncol 1995; 14: 113
- McGuire W P, Rowinsky E K, Rosenheim M B, et al. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989; 111: 273–279
- Murphy W K, Fosella F V, Winn R J, et al. Phase II study of taxol in untreated advanced non-small cell lung cancer. J Natl Cancer Inst 1993; 85: 384–388
- Ajani J A, Ilson D H, Daugherty K, et al. Paclitaxel in the treatment of carcinoma of the esophagus. Semin Oncol 1995; 22(Suppl 6)35–40
- Li W W, Cordon-Cardo C, Chen Q, et al. Establishment, characterization and drug sensitivity of four new human soft tissue sarcoma cell lines. Int J Cancer 1996; 68: 514
- Adult Intergroup Soft-Tissue Sarcoma Committee: Recommendations for clinical protocol development and definition of therapeutic response for soft tissue sarcoma. Cancer 1980; 46: 796–800
- Balcerzak S P, Benedetti J, Weiss G R, Natale R B. A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. Cancer 1995; 76: 2248–2252
- Gian V., Lynch J, McCarley D., Johnson T. Taxol in the treatment of recurrent or metastatic soft tissue or osteosarcomas. Proc Am Soc Clin Oncol 1995; 14: 516
- Patel S R, Papadopoulos N E, Plager C, et al. Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variants. Cancer 1996; 78: 741–744
- Van Hoesl Q GC, Verweij M., Catimal J. G, et al. Phase II study with Docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. Ann Oncol 1994; 5: 539–542